Published in J Bacteriol on November 01, 1977
Immunodominant major outer membrane proteins of Ehrlichia chaffeensis are encoded by a polymorphic multigene family. Infect Immun (1998) 3.02
Bacterial resistance to the tetracyclines. Microbiol Rev (1978) 2.52
Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide. Antimicrob Agents Chemother (1986) 1.33
Comparison of the polypeptide composition of Escherichia coli outer membranes prepared by two methods. J Bacteriol (1980) 1.29
Effect of heat and 2-mercaptoethanol on intracytoplasmic membrane polypeptides of Rhodopseudomonas sphaeroides. J Bacteriol (1978) 1.29
Energetics of tetracycline transport into Escherichia coli. Antimicrob Agents Chemother (1984) 0.93
Bacteriolysis of Veillonella alcalescens by lysozyme and inorganic anions present in saliva. Infect Immun (1981) 0.92
Lytic sensitivity of Actinobacillus actinomycetemcomitans Y4 to lysozyme. Infect Immun (1983) 0.90
A rapid method of total lipid extraction and purification. Can J Biochem Physiol (1959) 173.74
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem (1969) 142.11
High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 133.45
Mechanism of assembly of the outer membrane of Salmonella typhimurium. Isolation and characterization of cytoplasmic and outer membrane. J Biol Chem (1972) 29.60
Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands. FEBS Lett (1975) 26.78
Transduction of lactose-utilizing ability among strains of E. coli and S. dysenteriae and the properties of the transducing phage particles. Virology (1960) 11.82
Beginning a genetic analysis of conjugational transfer determined by the F factor in Escherichia coli by isolation and characterization of transfer-deficient mutants. J Bacteriol (1971) 8.45
Outer membrane of Salmonella typhimurium. Transmembrane diffusion of some hydrophobic substances. Biochim Biophys Acta (1976) 7.44
Structure and function of the cell envelope of gram-negative bacteria. Bacteriol Rev (1974) 7.42
Identification of the outer membrane protein of E. coli that produces transmembrane channels in reconstituted vesicle membranes. Biochem Biophys Res Commun (1976) 7.31
Covalent lipoprotein from the outer membrane of Escherichia coli. Biochim Biophys Acta (1975) 6.25
Influence of cultural conditions and mutations on the composition of the outer membrane proteins of Escherichia coli. Mol Gen Genet (1976) 5.45
The major proteins of the Escherichia coli outer cell-envelope membrane. Heterogeneity of protein I. Eur J Biochem (1976) 4.18
Outer membrane of Salmonella XIV. Reduced transmembrane diffusion rates in porin-deficient mutants. Biochem Biophys Res Commun (1976) 3.78
BETA-GALACTOSIDASE OF STREPTOCOCCUS LACTIS. J Bacteriol (1965) 3.59
The major proteins of the Excherichia coli outer cell envelope membrane. Preparative isolation of all major membrane proteins. Eur J Biochem (1975) 3.55
Outer membrane as a diffusion barrier in Salmonella typhimurium. Penetration of oligo- and polysaccharides into isolated outer membrane vesicles and cells with degraded peptidoglycan layer. J Biol Chem (1975) 3.34
Mutants of Escherichia coli K12 lacking all 'major' proteins of the outer cell envelope membrane. FEBS Lett (1975) 3.13
A three-dimensional molecular assembly model of a lipoprotein from the Escherichia coli outer membrane. Proc Natl Acad Sci U S A (1974) 3.09
Peptidoglycan-associated outer membrane proteins in gammegatine bacteria. Biochim Biophys Acta (1977) 3.00
The role of the bacterial cell envelope in antibiotic resistance. J Antimicrob Chemother (1975) 2.59
Lipoprotein from the outer membrane of Escherichia coli: purification, paracrystallization, and some properties of its free form. J Bacteriol (1976) 2.52
Cross-linking of the proteins in the outer membrane of Escherichia coli. Biochim Biophys Acta (1977) 2.26
Cytoplasmic membrane vesicles of Escherichia coli. A simple method for preparing the cytoplasmic and outer membranes. J Biochem (1975) 2.26
Mechanism of plasmic-mediated resistance to cadmium in Staphylococcus aureus. Antimicrob Agents Chemother (1975) 1.72
Gel electrophoresis of mucous glycoproteins. I. Effect of gel porosity. Biochemistry (1971) 1.53
Mutants of Escherichia coli "cryptic" for certain periplasmic enzymes: evidence for an alteration of the outer membrane. J Bacteriol (1977) 1.41
Mutational change of membrane architecture. Mutants of Escherichia coli K12 missing major proteins of the outer cell envelope membrane. Biochim Biophys Acta (1976) 1.39
Biochemical and genetic basis of tetracycline resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1974) 1.20
Nearest-neighbor analysis of Escherichia coli outer membrane proteins using cleavable cross-links. J Bacteriol (1976) 1.16
The major proteins of the Escherichia coli outer cell-envelope membrane. Cyanogen bromide fragments of protein I, composition and order. Eur J Biochem (1975) 1.16
Conformational studies on murein-lipoprotein from the outer membrane of Escherichia coli. Eur J Biochem (1976) 1.04
Structure and biosynthesis of functionally defined areas of the Escherichia coli outer membrane. Ann N Y Acad Sci (1974) 1.01
Architecture of the outer membrane of Escherichia coli K12. I. Action of phospholipases A2 and C on wild type strains and outer membrane mutants. Biochim Biophys Acta (1977) 0.91
Discussion paper: biosynthesis and assembly of a structural lipoprotein in the envelope of Escherichia coli. Ann N Y Acad Sci (1974) 0.86
Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis (1993) 4.74
Bacterial resistance to the tetracyclines. Microbiol Rev (1978) 2.52
The tetracyclines: prospects at the beginning of the 1980s. J Antimicrob Chemother (1981) 2.33
Genetic studies of a multi-resistant strain of Staphylococcus aureus. J Med Microbiol (1974) 2.19
Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic. Biochem Biophys Res Commun (1980) 1.98
Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob Agents Chemother (1998) 1.92
Molecular basis of beta-lactamase induction in bacteria. Antimicrob Agents Chemother (1993) 1.89
A variety of Staphylococcal plasmids present as multiple copies. J Gen Microbiol (1973) 1.85
Mechanisms of resistance to fusidic acid in Staphylococcus aureus. J Gen Microbiol (1976) 1.81
Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli. J Gen Microbiol (1980) 1.80
Organic acids: chemistry, antibacterial activity and practical applications. Adv Microb Physiol (1991) 1.78
Mechanism of plasmic-mediated resistance to cadmium in Staphylococcus aureus. Antimicrob Agents Chemother (1975) 1.72
Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother (1991) 1.69
Transport of antibiotics into bacteria. Adv Microb Physiol (1982) 1.62
Decreased uptake of cadmium by a resistant strain of Staphylococcus aureus. J Gen Microbiol (1970) 1.60
Diffusion of tetracycline across the outer membrane of Escherichia coli K-12: involvement of protein Ia. Biochem Biophys Res Commun (1978) 1.55
Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother (2006) 1.54
Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob Agents Chemother (1992) 1.53
Analysis of tetracycline resistance encoded by transposon Tn10: deletion mapping of tetracycline-sensitive point mutations and identification of two structural genes. J Bacteriol (1983) 1.53
Tetracycline resistance genes from Bacillus plasmid pAB124 confer decreased accumulation of the antibiotic in Bacillus subtilis but not in Escherichia coli. J Bacteriol (1981) 1.52
Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol (2007) 1.49
Reduced expression of Tn 10-mediated tetracycline resistance in Escherichia coli containing more than one copy of the transposon. J Gen Microbiol (1981) 1.48
Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother (2007) 1.48
Effect of short-chain organic acids on macromolecular synthesis in Escherichia coli. J Appl Bacteriol (1990) 1.41
Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli. J Gen Microbiol (1982) 1.40
Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J Antimicrob Chemother (2002) 1.33
Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide. Antimicrob Agents Chemother (1986) 1.33
RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (2000) 1.31
Antimicrobial properties and mode of action of the pyrrothine holomycin. Antimicrob Agents Chemother (2001) 1.31
Comparison of the polypeptide composition of Escherichia coli outer membranes prepared by two methods. J Bacteriol (1980) 1.29
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother (2001) 1.25
Biochemical and genetic basis of tetracycline resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1974) 1.20
Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother (2008) 1.20
Penicillin-binding protein 2 is required for induction of the Citrobacter freundii class I chromosomal beta-lactamase in Escherichia coli. Antimicrob Agents Chemother (1989) 1.20
Short-chain organic acids at ph 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J Appl Bacteriol (1991) 1.17
Effect of plasmid carriage on the virulence of staphylococcus aureus. J Med Microbiol (1975) 1.16
Polymorphonuclear cell function in rheumatoid arthritis and in Felty's syndrome. Ann Rheum Dis (1981) 1.15
Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes. Antimicrob Agents Chemother (1992) 1.13
Bacterial resistance mechanisms as therapeutic targets. J Antimicrob Chemother (1994) 1.09
Induction of tetracycline resistance in Staphylococcus aureus in the absence of lipid synthesis. J Gen Microbiol (1975) 1.08
Towards new business models for R&D for novel antibiotics. Drug Resist Updat (2011) 1.08
Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli. J Antimicrob Chemother (1986) 1.08
Expression of the Staphylococcus aureus UDP-N-acetylmuramoyl- L-alanyl-D-glutamate:L-lysine ligase in Escherichia coli and effects on peptidoglycan biosynthesis and cell growth. J Bacteriol (1999) 1.07
SB 205952, a novel semisynthetic monic acid analog with at least two modes of action. Antimicrob Agents Chemother (1995) 1.07
Resistance to beta-lactams in Mycobacterium fortuitum. Antimicrob Agents Chemother (1992) 1.06
Distribution of fusidic acid resistance determinants in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 1.06
High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis. J Antimicrob Chemother (2008) 1.05
Evidence for mutation to streptomycin resistance in clinical strains of Staphylococcus aureus. J Gen Microbiol (1972) 1.05
Genetic analysis of the tetA(C) gene on plasmid pBR322. J Bacteriol (1992) 1.01
Particulate contaminants of intravenous medications and infusions. J Pharm Pharmacol (1987) 1.01
Emergence and maintenance of resistance to fluoroquinolones and coumarins in Staphylococcus aureus: predictions from in vitro studies. J Antimicrob Chemother (2007) 1.01
Mutations affecting penicillin-binding proteins 2a, 2b and 3 in Bacillus subtilis alter cell shape and peptidoglycan metabolism. J Gen Microbiol (1987) 0.98
The antibacterial effects of low concentrations of antibiotics. Adv Microb Physiol (1986) 0.98
Stabilization of Rhizobium symbiosis plasmids. Microbiology (1999) 0.97
Accumulation of tetracyclines by Escherichia coli K-12. Biochem Biophys Res Commun (1977) 0.97
Energetics of tetracycline transport into Escherichia coli. Antimicrob Agents Chemother (1984) 0.93
Affinities of beta-lactams for penicillin binding proteins of Chlamydia trachomatis and their antichlamydial activities. Antimicrob Agents Chemother (2001) 0.91
Biochemical and genetic characterization of the tet determinant of Bacillus plasmid pAB124. J Bacteriol (1984) 0.90
Inhibition of Escherichia coli K12 by short-chain organic acids: lack of evidence for induction of the SOS response. J Appl Bacteriol (1991) 0.88
Delayed postoperative intracerebral abscess caused by Proprionibacterium acnes: case report and review of the literature. Br J Neurosurg (2003) 0.87
Antibacterial activity and mode of action of tert-butylhydroquinone (TBHQ) and its oxidation product, tert-butylbenzoquinone (TBBQ). J Antimicrob Chemother (2013) 0.87
Origin of tetracycline efflux proteins: conclusions from nucleotide sequence analysis. Mol Microbiol (1991) 0.86
Antibiotic resistance resulting from decreased drug accumulation. Br Med Bull (1984) 0.86
Limitations of a fluorescence assay for studies on tetracycline transport into Escherichia coli. Antimicrob Agents Chemother (1983) 0.84
Outer membrane composition in Escherichia coli and the poor activity of hydrophobic antibiotics against enteric bacteria. J Antimicrob Chemother (1982) 0.83
Uptake of tetracycline by Escherichia coli is not mediated by the sodium dependent glutamate transport system. J Antimicrob Chemother (1990) 0.83
Mode of action of the cyclic depsipeptide antibiotic LL-AO341 beta 1 and partial characterization of a Staphylococcus aureus mutant resistant to the antibiotic. J Antimicrob Chemother (1993) 0.83
Methotrexate: long-term safety and efficacy in an Australian consultant rheumatology practice. Intern Med J (2009) 0.83
Induction of the Citrobacter freundii group I beta-lactamase in Escherichia coli is not dependent on entry of beta-lactam into the cytoplasm. Antimicrob Agents Chemother (1990) 0.82
Use of mutator strains for characterization of novel antimicrobial agents. Antimicrob Agents Chemother (2001) 0.82
Polymorphonuclear motility: measurement by computer-linked image analysis. Blood (1980) 0.81
Cytokines modulate type I iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat thyroid cells. Mol Cell Endocrinol (1994) 0.81
Intradural metastatic spinal cord compression from ACTH-secreting pituitary carcinoma. Acta Neurochir (Wien) (2004) 0.81
Inhibition of beta-lactamase synthesis in Staphylococcus aureus by minocycline. J Antimicrob Chemother (1985) 0.80
Inhibition of Providencia stuartii cell envelope enzymes by chlorhexidine. J Antimicrob Chemother (1987) 0.80
Transcriptional signature following inhibition of early-stage cell wall biosynthesis in Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.80
Secondary screening for osteoporosis in patients admitted with minimal-trauma fracture to a major teaching hospital. Intern Med J (2003) 0.79
The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss. Aust N Z J Med (1977) 0.79
Susceptibility of protein synthesis in Escherichia coli to tetracycline and minocycline. J Gen Microbiol (1981) 0.79
Chronic sternal wound infection and endocarditis with Coxiella burnetii. Clin Infect Dis (1999) 0.79
Lack of correlation between methicillin resistance and susceptibility to lysostaphin in Staphylococcus aureus. J Gen Microbiol (1974) 0.79
Haemangioblastoma: a rare cause of a cerebellar mass in the elderly. Br J Neurosurg (2003) 0.79
Genetic and biochemical basis of tetracycline resistance. J Antimicrob Chemother (1986) 0.78
Transport of tetracyclines into Escherichia coli requires a carboxamide group at the C2 position of the molecule. J Antimicrob Chemother (1986) 0.78
Antibacterial spectra of drugs used for chemotherapy of mycobacterial infections. Tuber Lung Dis (1998) 0.78
Rapid methods for testing the efficacy of sterilization-grade filter membranes. Appl Environ Microbiol (2000) 0.77
Tetracycline resistance in Escherichia coli K12 is not associated with a decrease in cyclopropane fatty acid content. J Gen Microbiol (1977) 0.77
An assay to detect inhibitors of bacterial iron transport. J Antibiot (Tokyo) (1994) 0.77
Plasmid-determined tetracycline resistance in Escherichia coli K12: lack of evidence that resistance is related to changes in lipid metabolism [proceedings]. Biochem Soc Trans (1978) 0.77
Inhibition of K88-mediated adhesion of Escherichia coli to mammalian receptors by antibiotics that affect bacterial protein synthesis. J Antimicrob Chemother (1986) 0.77
Triiodothyronine (T3) reflects renal graft function after renal transplantation. Clin Endocrinol (Oxf) (1997) 0.76
Robust and sensitive nylon hybridization membrane suitable for high-throughput robotic arraying applications. Biotechniques (2002) 0.75
Pilocytic astrocytoma mimicking craniopharyngioma: a case series. Ann R Coll Surg Engl (2012) 0.75
Paradoxical response and tolerance in a strain of Staphylococcus aureus. J Antimicrob Chemother (1994) 0.75
The significance of triiodothyronine. Calif Med (1973) 0.75
Antibiotics and bacterial adhesion. J Antimicrob Chemother (1986) 0.75
Loose cilium in meibomian gland: mimicking early postoperative endophthalmitis. Eye (Lond) (2006) 0.75